Latest Diagnostic tests Stories
Part of agency's efforts to promote development of personalized medicines and diagnostics SILVER SPRING, Md., July 12, 2011 /PRNewswire-USNewswire/ --The U.S.
When a person living in a malarial area gets a fever, health workers need to know the cause to make absolutely sure they give the right treatment.
NEW YORK and QUEBEC CITY, June 29, 2011 /PRNewswire/ -- Signal Genetics, a privately held predictive genetic testing company focusing on oncology, and DiagnoCure, Inc.
IRVINE, Calif., June 17, 2011 /PRNewswire/ -- ResearchDx, LLC of Irvine, California today announced a strategic partnership with CompanDX of Nottingham UK.
SAN DIEGO, June 7, 2011 /PRNewswire/ -- bioTheranostics, Inc., a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE IDÂ®, and Breast Cancer Index(SM).
UNION CITY, Calif., June 7, 2011 /PRNewswire/ -- Abaxis, Inc.
QUEBEC CITY, June 6, 2011 /PRNewswire/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the second quarter of fiscal 2011.
BEIJING, June 1, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc.
QUEBEC CITY, March 11 /PRNewswire-FirstCall/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the first quarter of fiscal 2011.